https://www.globenewswire.com/news-release/2022/11/10/2553533/0/en/Immutep-Announces-Compelling-Clinical-Results-from-Phase-II-Trial-Utilizing-its-First-in-Class-Soluble-LAG-3-Protein-Eftilagimod-Alpha-in-1st-Line-NSCLC-at-SITC-2022-Annual-Meeting.html
- Forums
- ASX - By Stock
- INSIGHT-003 ORR 72.7% DCR 90.9% (Initial Data)
https://www.globenewswire.com/news-release/2022/11/10/2553533/0/e...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
36.8¢ |
Change
-0.013(3.29%) |
Mkt cap ! $551.9M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 36.5¢ | $152.1K | 410.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 129694 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 84085 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 105503 | 0.365 |
13 | 104064 | 0.360 |
15 | 132796 | 0.355 |
13 | 225761 | 0.350 |
4 | 45169 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 84620 | 13 |
0.375 | 121493 | 11 |
0.380 | 159552 | 10 |
0.385 | 86271 | 7 |
0.390 | 288140 | 11 |
Last trade - 11.12am 29/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online